Literature DB >> 15017078

Adenovirus-delivered siRNA.

Changxian Shen1, Sven N Reske.   

Abstract

RNA interference is the process that double-stranded RNA (dsRNA) induces the homology-dependent degradation of cognate mRNA mediated by 21- to 23-nt small interfering RNA (siRNA). Successful application of RNAi in functional genomics and proteomics, cancer gene therapy, and virus protection depends on the efficient delivery of siRNA into mammalian cells. The availability of high virus titer, infection of a broad spectrum of cell types, and independence on active cell division makes adenovirus the vector of choice for siRNA delivery. To this end, we developed a new adenovirus shuttle vector designated as pShuttle-H1 to host H1-RNA promoter and unique BglII and HindIII sites for insertion of oligos for expression of siRNA. In this chapter, we describe an adenovirus system that uses a commercially available adenovirus system and pShuttle-H1 to deliver siRNA-expressing cassette into cells to silence a specific gene in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017078     DOI: 10.1385/1-59259-746-7:523

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Adenovirus-Mediated Small Interfering RNA Targeting TAK1 Ameliorates Joint Inflammation with Collagen-Induced Arthritis in Mice.

Authors:  Xinjing Luo; Yongfeng Chen; Guoju Lv; Zhidong Zhou; Jie Chen; Xuanrong Mo; Jiangwen Xie
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

2.  Inhibition of West Nile Virus replication by retrovirus-delivered small interfering RNA in human neuroblastoma cells.

Authors:  Yongbo Yang; Chengxiang Wu; Jianguo Wu; Vivek R Nerurkar; Richard Yanagihara; Yuanan Lu
Journal:  J Med Virol       Date:  2008-05       Impact factor: 2.327

3.  Efficient in vivo knock-down of estrogen receptor alpha: application of recombinant adenovirus vectors for delivery of short hairpin RNA.

Authors:  Yvonne D Krom; Frits J Fallaux; Ivo Que; Clemens Lowik; Ko Willems van Dijk
Journal:  BMC Biotechnol       Date:  2006-02-28       Impact factor: 2.563

Review 4.  Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.

Authors:  Yuan Zhang; Juhura G Almazi; Hui Xin Ong; Matt D Johansen; Scott Ledger; Daniela Traini; Philip M Hansbro; Anthony D Kelleher; Chantelle L Ahlenstiel
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

Review 5.  RNA interference as a novel treatment strategy for chronic hepatitis B infection.

Authors:  Rex Wan-Hin Hui; Lung-Yi Mak; Wai-Kay Seto; Man-Fung Yuen
Journal:  Clin Mol Hepatol       Date:  2022-02-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.